China Pharma Holdings, Inc.
CPHI
$0.65
-$0.01-1.39%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.19M | -3.19M | -3.66M | -4.57M | -4.74M |
| Total Depreciation and Amortization | 1.58M | 1.51M | 1.85M | 2.27M | 2.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.11M | 522.80K | 464.50K | 546.50K | 458.60K |
| Change in Net Operating Assets | 14.87M | 1.45M | 1.82M | 1.87M | 1.19M |
| Cash from Operations | 148.30K | 295.10K | 485.10K | 121.30K | -406.10K |
| Capital Expenditure | -59.30K | -78.30K | -68.50K | -96.70K | -38.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.90K | -325.90K | -285.90K | -275.90K | -253.30K |
| Cash from Investing | -137.30K | -404.40K | -354.60K | -372.80K | -291.80K |
| Total Debt Issued | 961.10K | 260.30K | 1.01M | 520.10K | 520.10K |
| Total Debt Repaid | -1.26M | -536.00K | -1.15M | -630.70K | -553.90K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -100.00 | 0.00 |
| Cash from Financing | -294.00K | -275.70K | -146.70K | -110.60K | -33.70K |
| Foreign Exchange rate Adjustments | 1.30K | -66.00K | -98.20K | -64.20K | -65.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -281.80K | -451.10K | -114.30K | -426.10K | -796.90K |